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Abstract
Background: The objective of this study was to assess the responsiveness of the Minimum Data
Set Activities of Daily Living (MDS-ADL) Scale to change over time by examining the change in
physical function in adults with moderate to severe dementia with no comorbid illness who had
been resident in a nursing home for over 90 days.
Methods: Longitudinal data were collected on nursing home residents with moderate (n = 7001)
or severe (n = 4616) dementia in one US state from the US national Minimum Data Set (MDS).
Severity of dementia was determined by the MDS Cognitive Performance Scale (CPS). Physical
function was assessed by summing the seven items (bed mobility, transfer, locomotion, dressing,
eating, toilet use, personal hygiene) on the MDS activities of daily living (ADL) Long Form scale.
Mean change over time of MDS-ADL scores were estimated at three and six months for residents
with moderate (CPS score of 3) and severe (CPS score of 4 or 5) dementia.
Results: Physical function in residents with moderate cognitive impairment deteriorated over six
months by an average of 1.78 points on the MDS-ADL Long Form scale, while those with severe
cognitive impairment declined by an average of 1.70 points. Approximately one quarter of residents
in both groups showed some improvement in physical function over the six month period.
Residents with moderate cognitive impairment experienced the greatest deterioration in early-loss
and mid-loss ADL items (personal hygiene, dressing, toilet use) and residents with severe cognitive
impairment showed the greatest deterioration in activities related to eating, a late loss ADL.
Conclusion: The MDS-ADL Long Form scale detected clinically meaningful change in physical
function in a large cohort of long-stay nursing home residents with moderate to severe dementia,
supporting its use as a research tool in future studies.
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Dementia, characterised by a progressive decline in cogni-
tive function, affects up to 11 percent of those 65 and
over, and 25 to 47 percent of those over the age of 85 [1].
Dementia adversely affects physical function, as measured
by dependence in activities in daily living (ADL) [2-6].
Such decline causes a substantial burden for patients, their
caregivers and society as a whole as patients become more
dependent on caregiver and paid professional support,
leading to increasing costs of care [7]. A loss of independ-
ence in activities of daily living is a key determinant of
patient health-related quality of life [8] and a predictor of
institutionalisation and mortality [9-11].
Dementia is widely prevalent in nursing homes residents
[12,13], however few studies have assessed how physical
function changes over time in nursing home residents
with different levels of severity of cognitive impairment.
The relationship between cognition and ADL has become
an increasingly important area of dementia research as it
can help to inform treatment decisions and it can help in
the understanding of the value of new generations of
pharmaceutical agents which aim to enhance cognitive
function [14]. Previous studies that have assessed change
over time have described change during the first 90 days
of stay and therefore incorporated the confounding effects
of change immediately after admission to a nursing home
[15]. Other investigations included residents with comor-
bid illness, thus confounding the extent of the association
between dependence in ADL and severity of dementia
[16,17].
The Minimum Dataset Set (MDS) provides extensive data
on residents of nursing homes. It was introduced in the
United States in the early 1990s in response to the United
States Congress in the Omnibus Budget Reconciliation Act
of 1987 [18] and includes the mandatory requirement of
data collection on cognition and ADL. The MDS is a uni-
fied, comprehensive needs assessment system used by
professionals from multiple disciplines. It was developed
through clinical reviews, tested in nursing homes and
evaluated for validity and reliability [18]. A full assess-
ment is performed on admission and annually thereafter,
with a reduced quarterly assessment done every 90 days.
Since implementation nationwide in the US, the MDS
assessment tools have been introduced for care needs
assessment and care planning in many countries around
the world.
Although the primary aim for the development of the
MDS is to improve the quality of care in nursing homes, it
also provides a unique database for researchers. A number
of studies have assessed the validity of specific MDS rating
scales and commented on their usefulness as research
tools [19,20]. MDS rating scales for physical function
have been validated against other standardised instru-
ments, however few studies have assessed how well these
MDS ADL scales measure change over time [19].
This study aims to assess the responsiveness of the MDS-
ADL scale to change over time by examining the change in
physical function in adults with moderate and severe
dementia with no comorbid illness who have been resi-
dent in a nursing home for over 90 days. We excluded res-
idents with very severe dementia as they were likely to be
already severely physically impaired, and those with very
mild dementia as decline in ADL was less likely to be
related directly to cognitive impairment.
Methods
Study design and population
This study was a longitudinal analysis of a representative
sample of nursing home residents in one US state. MDS
assessments for residents with a length of stay of greater
than 90 days in the year 2002 were collected from a US
National Resident Assessment Instrument database (n =
66,742) and follow-up data were extracted at three and six
months [21]. We chose three month intervals between
assessments to enable more precise examination of the
rate and direction of change than is available in many lon-
gitudinal studies with assessment intervals of a year or
more [22,23]. Residents with an expectation of being dis-
charged prior to 90 days were excluded (n = 1998).
In order to minimise the effect of factors, other than cog-
nitive impairment, in relation to change in ADL, residents
were excluded if they had specific co-morbid diseases or
conditions, or received specific treatments. These
included history of learning disability, decreased auditory
and visual acuity, problems with expressive speech, hypo-
tension, seizure disorder, traumatic brain injury, manic
depression, schizophrenia, HIV infection, septicaemia,
weight fluctuation, inability to lay flat due to shortness of
breath, dehydration, insufficient fluid consumption,
internal bleeding, recurrent lung aspiration, end stage of
disease, feeding by parenteral/IV or feeding tube, treat-
ment including chemotherapy, radiation, tracheotomy
care, transfusion, ventilator, for alcohol/drug problems,
hospice care and respite care. Residents with concurrent or
pre-existing limitations to mobility such as hip fracture,
missing limb, bone fracture, cerebral palsy, stroke, hemi-
plegia/paresis, multiple sclerosis, paraplegia, Parkinson
disease, or quadriplegia were also excluded. After applying
these exclusions, the total number of residents available
for study was 21,670. The most common reasons for
exclusion were stroke (23%), presence of a learning disa-
bility (19%), impaired vision (10%) and hip fracture
(5%). Nearly 40% of the sample had two or more of these
exclusion criteria.Page 2 of 8
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Cognitive impairment was measured using the MDS Cog-
nitive Performance Scale (CPS), which classifies all resi-
dents into seven levels of cognitive performance ranging
from a score of '0' (intact) to '6' (very severe impairment).
These scores are derived from four MDS variables – two
cognitive items (short-term memory and decision-mak-
ing), one communication item (ability to make self
understood) and one ADL item (eating). The CPS meas-
ure of cognitive impairment correlates highly with well
accepted and frequently used research rating scale scores,
including Folstein's Mini-Mental Status Examination
(MMSE) [19,24-26]. This study examined the patterns of
change in ADL for those residents with moderate to severe
cognitive impairment therefore the CPS was used to iden-
tify residents in two groups: those with a CPS score of 3
(mean MMSE 15) and classified as moderate impairment
(n = 7001) and those with a CPS score of 4 or 5 (mean
MMSE 5–6) and classified as severe impairment (n =
4616). This method of classification has been used in
other studies [16,17]. Residents with CPS scores of 0, 1, 2
(mild cognitive impairment) and 6 (very severe cognitive
impairment) were excluded from the analysis.
Assessment of activities of daily living
Change in ADL was measured using the MDS-ADL scale,
which has also been validated against a number of stand-
ardised instruments for measuring physical function [26-
28]. This study used the ADL Long Form scale of the MDS
which is composed of seven ADL items. This scale is the
most sensitive to change over time of the three principal
summary MDS-ADL scales available [29]. The seven items
are outlined in Table 1. Each ADL item has six possible
categories of response representing observation by a
trained clinical professional over an assessment period of
seven days. Assessments based on observed rather than
self-reported physical function were considered to be
more reliable with high-risk groups such as residents with
cognitive impairment, given that discrepancies can arise
between the two methods of data capture [30]. The cate-
gories of response for the MDS-ADL self-performance
scores range from 0 (total independence) to 4 (total
dependence). The MDS Long Form ADL scale is a sum of
the responses to all the seven individual ADL items and
has a range from '0' to '28', with higher scores indicating
a greater dependence [29].
Baseline ADL scores were documented for each long-stay
resident, using data from their earliest MDS-ADL assess-
ment. Follow-up was assembled from assessments col-
lected three and six months after this baseline assessment.
In this way, the study includes long-stay residents with a
range of nursing home lengths of stay in excess of 90 days.
Analytic approach
We report here on the mean score calculated at baseline
and at the three and six month follow-up, both for the
overall ADL scale and for each of the seven individual
ADL items. Mean change was calculated from baseline to
three and six months for both cognitive impairment
groups, and we report mean change, standard deviations
(SD) and 95% confidence intervals (CI).
Ethical review
The data used in this study were extracted from an aggre-
gated anonymised database and submission to a research
ethics committee was not required.
Results
Sample characteristics and loss to follow-up
The demographics and status at the three and six month
follow-up are presented in Table 2. The moderate impair-
ment group had a mean age (SD) of 85.6 (8.9) years and
80% were female. The proportion of those with moderate
impairment no longer in residency at three months fol-
low-up was 7% increasing to 18% by the six-month fol-
low-up. The severe impairment group had similar
demographic characteristics (mean age of 85.4 (8.7) years
Table 1: The seven items included in the MDS-ADL Long Form scale.
Item* Description
Bed mobility This includes how a resident moves and turns their body position while in bed.
Transfer This includes how a resident moves between surfaces such as a bed and chair.
Locomotion This includes how a resident moves between locations in their room and corridor outside their room.
Dressing, This includes how a resident puts on, fastens, takes off all items of street clothing.
Eating This relates to how a resident eats and drinks, including other means of intake of nourishments such as tube feeding.
Toilet use This includes how a resident uses a toilet, commode, bedpan or urinal and transfer on and off the toilet.
Personal hygiene This relates to how personal hygiene is maintained, including combing hair, brushing teeth, washing and drying face and 
hands but excluding baths and showers.
* Categories of response to each item include: 0 (total independence or no or little help with an activity), 1 (supervision provided 3 or more times 
during last 7 days), 2 (limited assistance by staff with the resident highly involved in activity), 3 (extensive assistance by staff with the resident 
performing part of the activity), 4 (total dependence – full staff participation in activity during the entire 7 days) and 8 (activity did not occur). For 
this scale, category 8 was combined category 4.Page 3 of 8
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idency at three months, of whom a third had died. At six
months 21% were no longer in residency, of whom a fur-
ther 20% had died. Other reasons for loss to follow-up
included transfer to another nursing home or acute hospi-
tal (10% at 3 months and a further 5% at 6 months) and
discharge home or to another non hospital or nursing
home setting, but reasons were not known for about half
those who were not still resident at the three and six
month follow-up.
Mean level of physical function
In those with moderate cognitive impairment, mean ADL
score at baseline was 14.77 (SD 7.34). The distribution of
baseline scores for each ADL item is outlined in Figure 1.
Dependence on staff was highest for functions relating to
personal hygiene, dressing and toileting and lowest for
eating. Mean ADL score increased to 15.63 (SD 7.40) at
three months and 16.16 (SD 7.37) at six months (mean
change at 6 months 1.8, std. dev. 4.4). For residents with
severe cognitive impairment, the mean ADL score at base-
line was 19.01 (SD 6.09). The distribution of ADL item
scores for this group shows that dependence was highest
for dressing, where 89% of residents required extensive or
full assistance from staff, and lowest again for eating (Fig-
ure 1). The mean ADL score increased to 19.79 (6.16) at
three months and 20.27 (6.07) at six months (mean
change at 6 months 1.7, std. dev. 3.9).
Change in physical function over time
Tables 3 and 4 show the change in ADL scores from base-
line to three and six months for overall ADL score and for
each of the seven individual ADL items. By the end of the
six-month period, overall physical function of residents
with moderate cognitive impairment deteriorated signifi-
cantly by 1.78 points (95% CI; 1.67 to 1.91) and by 1.70
points (95% CI; 1.59 to 1.83) for residents with severe
impairment. Each ADL item showed a significant worsen-
ing at both three and six months for both groups. How-
ever, although overall 56% and 57% of residents with
moderate and severe impairment, respectively, showed a
decline in physical function at six months, a quarter of res-
idents in both groups showed an improvement. Fewer
than 30% of all residents at three months and 20% at six
months were relatively stable, i.e., not changing (positive
nor negative) more than one point in the ADL scale.
Residents in both cognitive groups showed a significant
decline in all seven individual ADL items. The percentage
of residents showing a decline ranged from 18% to 21%
Baseline MDS-ADL long form item scores for residents with moderate and severe cognitive impairmentFigure 1
Baseline MDS-ADL long form item scores for residents with moderate and severe cognitive impairment.
Total dependence 
Extensive assistance by staff 
Limited assistance by staff 
Some supervision required 
IndependentPage 4 of 8
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29% for the severe impairment group at the three month
assessment. This increased to ranges of 26% to 29% and
20% to 38% in the two cognitive groups, respectively,
after six months. The percentage of residents who
improved in each individual ADL item was smaller.
Between 10% to 12% of those with moderate impairment
and 9% and 13% in those with severe impairment
improved at three months, and between 10% to 13% and
10% to 12% at six months (Tables 3 and 4).
There were also between-group differences in the decline
rate for specific ADL's. A greater proportion of residents
with moderate cognitive impairment experienced a
decline in personal hygiene and dressing (early-loss ADLs
items) and in toileting functions (a mid loss ADL item).
At six months around 26% of residents with moderate
impairment experienced a decline in these functions com-
pared to around 21% with severe impairment. Although
the proportion of residents showing a decline in the func-
tion of eating (a late-loss ADL) was high for both groups,
it was highest for those with severe impairment (29%
moderate vs. 38% severe).
Discussion
This study was the first assessment of ADL change over
time using the MDS-ADL Long Form scale in long-stay
nursing home residents with moderate to severe cognitive
impairment, with no comorbid illness. The MDS-ADL
scale detected a mean decline in ADL for residents with
moderate and severe impairment of 1.78 and 1.70 points
respectively. A change of one point in the MDS-ADL scale
denotes a clinically meaningful change. An increase of
one point represents a precisely defined increased require-
Table 3: Mean change in physical function for each MDS-ADL Long Form item at 3 and 6 months for residents with moderate 
cognitive impairment (CPS = 3).
Change baseline to 3 months (n = 6518) Change baseline to 6 months (n = 5752)
Mean (SD) 95% CI % decline % improve Mean (SD) 95% CI % decline % improve
ADL Long 
Form
1.02 (3.77) 0.92–1.08 45.8 27.0 1.78 (4.46) 1.67–1.91 55.6 24.8
Bed mobility 0.16 (0.93) 0.14–0.18 19.5 10.7 0.27 (1.06) 0.25–0.29 25.8 11.6
Transfer 0.17 (0.90) 0.15–0.19 20.1 10.7 0.28 (0.99) 0.27–0.31 26.6 10.3
Locomotion 0.22 (1.27) 0.20–0.24 20.8 11.5 0.33 (1.40) 0.30–0.38 27.4 12.7
Dressing 0.12 (0.73) 0.10–0.14 19.0 10.2 0.19 (0.82) 0.17–0.21 25.6 11.1
Eating 0.18 (1.00) 0.15–0.19 21.0 12.1 0.32 (1.13) 0.31–0.35 28.5 12.0
Toileting 0.12 (0.80) 0.10–0.14 18.3 10.8 0.24 (0.91) 0.21–0.25 26.4 11.2
Personal 
hygiene
0.11 (0.70) 0.09–0.13 18.9 10.2 0.21 (0.80) 0.19–0.23 26.8 10.5
Table 2: Demographics and status at three and six month follow-up for long-stay residents with moderate and severe cognitive 
impairment
Moderate Impairment (CPS 3) N = 7001 Severe Impairment (CPS 4,5) N = 4616
Age (%)
< 75 906 (8.7) 383 (8.3)
75–84 2051 (29.3) 1477 (32.0)
85–94 3501 (50.0) 2216 (48.0)
95+ 840 (12.0) 540 (11.7)
Gender (%)
Male 1429 (20.4) 926 (20.1)
Female 5572 (79.6) 3690 (79.9)
Status at 3 months follow-up (%)
Still resident in NH 6518 (93.1) 4254 (92.2)
Discharged or transferred 65 (0.9) 40 (0.9)
Deceased 160 (2.3) 125 (2.7)
Lost to follow-up 258 (3.7) 201 (4.3)
Status at 6 month follow-up (%)
Still resident in NH 5752 (82.2) 3642 (78.9)
3642 (78.9) 138 (2.0) 87 (1.9)
Deceased 360 (5.1) 320 (6.9)
Lost to follow-up 751 (10.7) 567 (12.3)Page 5 of 8
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sis and the extensive reviews and debriefings during the
original development of the MDS-RAI [31]. Not only does
this represent a change in the abilities of an individual,
but also a change in the cost of their care. This study,
which demonstrated a mean change of 1.7 points over six
months based on a sample of 11,617 nursing home resi-
dents, shows that the MDS-ADL Long Form scale is sensi-
tive to clinically relevant change over time in residents
with moderate to severe cognitive impairment.
Furthermore, the study demonstrates that long-stay nurs-
ing home residents with moderate to severe cognitive
impairment without comorbid illness have a high degree
of physical impairment requiring assistance from staff in
activities of daily living. Over time there is a general
decline in ADL, indicating greater support is needed from
nursing home staff. Comparison between the two demen-
tia groups suggests a direct relationship between cognitive
impairment and change in physical function over time;
the more severe the cognitive impairment the more ADL
items are likely to have been lost already, and the more
likely they will continue to be lost in the ensuing months.
A higher proportion of residents with moderate cognitive
impairment experienced a decline in the early and mid-
loss ADLs (personal hygiene, dressing and toileting) com-
pared to those more severely impaired. Residents with
severe cognitive impairment showed the greatest decline
in eating, a late-loss ADL. The main reason for the rela-
tively small change in early and mid-loss ADLs (personal
hygiene, dressing and toileting) for residents with severe
impairment is likely due to these residents already having
experienced substantial decline in these ADLs. This pat-
tern of ADL follows the hierarchy of early, mid and late
loss ADL originally outlined by Katz [32] and developed
further in other studies since [18,33-35], and illustrated in
the development of the MDS-ADL scales [29]. Early loss
ADLs are in decline even before entering a nursing home
and almost universally contribute to the reasons for
admission [10,11,35].
Two other studies have assessed ADL change using MDS
data. One study using the MDS-ADL 20-point scale in a
sample of long-stay nursing home residents with CPS
scores of 0 to 5 reported a mean change of 0.95 (SD 3.0)
over one year [16]. Another study, using the MDS-ADL
24-point scale, demonstrated only a 0.15 (SD 7.0) change
in residents with Alzheimer's' disease with at least one
year of follow-up. It concluded that the MDS-ADL scale
may be limited as an outcome measure as it would require
in excess of 3000 patients to detect statistically significant
changes [19]. However, this result was based on a very
small sample size (n = 60). This present study, which
demonstrated a clinically relevant mean change in MDS-
ADL of 1.8 (SD 4.4) for the moderate and 1.7 (SD 3.9) for
the severe group, suggests that statistical significance
would require sample sizes of no more than 200 in each
group, far fewer than the 3000 reported previously [19],
further supporting its use as a research tool [36].
The main limitation of this study was that the analysis of
ADL change over time does not include a number of resi-
dents who were lost to follow-up, either because they died
or moved from the nursing home. However, this propor-
tion was relatively small (19% at six months for both
groups combined). Those residents who died may have
shown a more marked decline in ADL compared to those
who remained in the study. The study is also limited by
the accuracy of the MDS dataset. However, for the cogni-
tive function and ADL measures a high degree of reliabil-
ity has been established [18].
This study supports existing evidence that despite the
decline in ADLs, some residents showed an improvement
in physical function – even long-stay residents with severe
cognitive impairment. Investigation of factors associated
with improvement and further research into interventions
Table 4: Mean change in physical function for each MDS-ADL Long Form item at 3 and 6 months for residents with severe cognitive 
impairment (CPS = 4 or 5).
Change baseline to 3 months (n = 4254) Change baseline to 6 months (n = 3642)
Mean (SD) 95% CI % decline % improve Mean (SD) 95% CI % decline % improve
ADL Long 
Form
0.94 (3.30) 0.88–1.08 48.0 25.4 1.70 (3.87) 1.59–1.83 57.3 22.7
Bed mobility 0.17 (0.91) 0.14–0.18 20.7 10.4 0.27 (1.03) 0.23–0.31 27.5 11.1
Transfer 0.16 (0.87) 0.14–0.18 19.9 10.4 0.28 (0.97) 0.24–0.32 26.8 10.2
Locomotion 0.20 (1.21) 0.17–0.25 20.3 11.0 0.34 (1.35) 0.31–0.39 28.1 11.6
Dressing 0.07 (0.60) 0.05–0.09 15.6 9.8 0.14 (0.66) 0.12–0.16 21.9 10.1
Eating 0.27 (1.04) 0.25–0.29 29.1 13.0 0.46 (1.15) 0.41–0.49 38.2 11.9
Toileting 0.08 (0.67) 0.07–0.11 16.7 9.9 0.15 (0.72) 0.13–0.17 21.6 10.1
Personal 
hygiene
0.05 (0.54) 0.04–0.08 14.6 9.4 0.12 (0.63) 0.10–0.14 20.2 9.7Page 6 of 8
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apy and the prescription of pharmaceuticals that alter the
rate of decline in cognitive function, will have the added
benefit of reducing the ever-increasing pressures on nurs-
ing home care staff and quality of life of cognitively
impaired residents. As the MDS assessment instrument is
widely used in routine clinical practice and has demon-
strated utility for pharmacoepidemiology [37-40], further
research on drug interventions for the cognitively
impaired or dementia patients should examine the effects
of change in physical function. It would build on evidence
from recent studies that have reported the relationship
between treatments and reduction in decline of activities
of daily living [14] ensuring that the residents and their
carers can gain maximum benefit from these new agents
for a common, distressing and debilitating condition.
Conclusion
Moderate to severe cognitive impairment was associated
with decline in physical function, which confirms previ-
ous studies. However, further to this, we provide evidence
of decline, and the rate of that decline, in a particularly
vulnerable group in a relatively short period of time. This
provides further supporting evidence for the use of the
MDS-ADL scale as a research tool. The study also supports
published research in the ordering of ADL loss into early,
mid and late loss ADLs and its association with cognitive
impairment. The more severe the cognitive impairment
the more likely the subject is to have experienced decline
in late loss ADLs. Most change in moderately impaired
was in the early-loss and the mid-loss ADLs. These results
could help direct the frequency and type of provision of
care given to cognitively impaired residents of nursing
homes and help inform future studies using MDS meas-
ures to assess the effect and cost benefits of interventions
on the progression of dementia.
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